Sepsis caused by new delhi metallo-β-lactamase (blaNDM-1) and qnrD-producing Morganella morganii, treated successfully with fosfomycin and meropenem: Case report and literature review

International Journal of Infectious Diseases

Volumn 30, Issue , 2015, Pages e20-e26

  Seija, Verónica ^a   Medina Presentado, Julio César ^b   Bado, Inés ^b   Papa Ezdra, Romina ^b   Batista, Noelia ^a   Gutierrez, Claudia ^a   Guirado, Mariana ^b   Vidal, Macarena ^b   Nin, Marcelo ^a   Vignoli, Rafael ^b  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^b Universidad de la Republica Instituto de Higiene   (Uruguay)

Author keywords

Fosfomycin; Meropenem; Morganella morganii; NDM 1; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIKACIN; ASPARTATE AMINOTRANSFERASE; BACTERIAL ENZYME; BETA LACTAMASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; C REACTIVE PROTEIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; CREATININE; ERTAPENEM; ESTERASE; FOSFOMYCIN; HEMOGLOBIN; IMIPENEM; MEROPENEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEW DELHI METALLO BETA LACTAMASE; NITRITE; PIPERACILLIN PLUS TAZOBACTAM; PREDNISONE; PROCALCITONIN; PROTEIN; PURINE DERIVATIVE; TACROLIMUS; UNCLASSIFIED DRUG; UREA; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA-LACTAMASE NDM-1; COLISTIN; THIENAMYCIN DERIVATIVE;

ABDOMINAL TENDERNESS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTERIAL OXYGEN SATURATION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL GENE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BILIRUBIN BLOOD LEVEL; BLOOD; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DYSURIA; EMERGENCY WARD; END STAGE RENAL DISEASE; ENTEROBACTER CLOACAE; ERYTHROCYTE; FEVER; GLOMERULONEPHRITIS; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IMMUNOCOMPROMISED PATIENT; JAUNDICE; KIDNEY GRAFT; LABORATORY TEST; LEUKOCYTE; LEUKOCYTE COUNT; LIVER FAILURE; LYMPHOCYTE COUNT; MALE; MEDICAL HISTORY; MICROSCOPY; MORGANELLA MORGANII; NEUTROPHIL COUNT; NUCLEOTIDE SEQUENCE; PANCYTOPENIA; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; QNR GENE; SEPSIS; SEQUENCE ANALYSIS; SOUTH AMERICA; SOUTH AND CENTRAL AMERICA; THORAX RADIOGRAPHY; THROMBOCYTE COUNT; UREA BLOOD LEVEL; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; URINE INCONTINENCE; URINE VOLUME; DRUG COMBINATION; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; GENETICS; MICROBIOLOGY; YOUNG ADULT;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; COLISTIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENTEROBACTERIACEAE INFECTIONS; FOSFOMYCIN; HUMANS; MALE; MORGANELLA MORGANII; SEPSIS; SOUTH AMERICA; THIENAMYCINS; YOUNG ADULT;

EID: 84916918543     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.09.010     Document Type: Article

References (61)

1. O'Hara C.M., Brenner F.W., Miller J.M. Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev 2000, 13:534-546.
2. Power P., Galleni M., Ayala J.A., Gutkind G. Biochemical and molecular characterization of three new variants of AmpC β-lactamases from Morganella morganii. Antimicrob Agents Chemother 2006, 50:962-967.
3. Leclercq R., Cantón R., Brown D.F., Giske C.G., Heisig P., MacGowan A.P., et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013, 19:141-160.
4. Nordmann P., Dortet L., Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends Mol Med 2012, 18:263-272.
5. Canton R., Akova M., Carmeli Y., Giske C.G., Glupczynski Y., Gniadkowski M., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012, 18:413-431.
6. Yong D., Toleman M.A., Giske C.G., Cho H.S., Sundman K., Lee K., et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009, 53:5046-5054.
7. Johnson A.P., Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013, 62:499-513.
8. Rolain J.M., Parola P., Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?. Clin Microbiol Infect 2010, 16:1699-1701.
9. Rodriguez-Martinez J.M., Cano M.E., Velasco C., Martinez-Martinez L., Pascual A. Plasmid-mediated quinolone resistance: an update. J Infect Chemother 2011, 17:149-182.
10. Cavaco L.M., Hasman H., Xia S., Aarestrup F.M. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob Agents Chemother 2009, 53:603-608.
11. Mazzariol A., Kocsis B., Koncan R., Kocsis E., Lanzafame P., Cornaglia G. Description and plasmid characterization of qnrD determinants in Proteus mirabilis and Morganella morganii. Clin Microbiol Infect 2012, 18:E46-E48.
12. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
13. Nordmann P., Poirel L., Carrer A., Toleman M.A., Walsh T.R. How to detect NDM-1 producers. J Clin Microbiol 2011, 49:718-721.
14. Garcia-Fulgueiras V., Bado I., Mota M.I., Robino L., Cordeiro N.F., Varela A., et al. Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. J Antimicrob Chemother 2011, 66:1725-1729.
15. Vignoli R., Cordeiro N., Seija V., Schelotto F., Radice M., Ayala J., et al. Genetic environment of CTX-M-2 in Klebsiella pneumoniae isolates from hospitalized patients in Uruguay. Rev Argent Microbiol 2006, 38:84-88.
16. Vignoli R., Cordeiro N.F., Garcia V., Mota M.I., Betancor L., Power P., et al. New TEM-derived extended-spectrum beta-lactamase and its genomic context in plasmids from Salmonella enterica serovar derby isolates from Uruguay. Antimicrob Agents Chemother 2006, 50:781-784.
17. García-Fulgueiras V., Bado I., Cordeiro N., Algorta G., Vignoli R. First report of the ceftazidimase CTX-M-19 in South America. New Microbes New Infect 2013, 1:44-47.
18. García-Fulgueiras V., Seija V., Aguerrebere P., Cordeiro N.F., Vignoli R. First report of a clinical isolate of Leclercia adecarboxylata harbouring multiple resistance genes in Uruguay and review of the literature. J Glob Antimicrob Resist; 2014, 2:77-81.
19. CMY-2 gene in Salmonella enterica serovar Typhimurium isolates obtained from cases of paediatric diarrhoea illness detected in South America. J Glob Antimicrob Resist 2013, 1:143-148.
20. Barrios H., Garza-Ramos U., Reyna-Flores F., Sanchez-Perez A., Rojas-Moreno T., Garza-Gonzalez E., et al. Isolation of carbapenem-resistant NDM-1-positive Providencia rettgeri in Mexico. J Antimicrob Chemother 2013, 68:1934-1936.
21. Thoms-Rodriguez C.A., Nicholson A., Christian N., Willey B., Didier H., Mataseje L., et al. The detection of the NDM-1 and other carbapenemase genes in multidrug resistant Gram negative bacilli (MDRGNB) in a Jamaican hospital. Int J Infect Dis 2012, 16(S1):e434-e435.
22. Pasteran F., Albornoz E., Faccone D., Gomez S., Valenzuela C., Morales M., et al. Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala. J Antimicrob Chemother 2012, 67:1795-1797.
23. Waterman P.E., McGann P., Snesrud E., Clifford R.J., Kwak Y.I., Munoz-Urbizo I.P., et al. Bacterial peritonitis due to Acinetobacter baumannii sequence type 25 with plasmid-borne New Delhi metallo-β-lactamase in Honduras. Antimicrob Agents Chemother 2013, 57:4584-4586.
24. Escobar Pérez J.A., Olarte Escobar N.M., Castro-Cardozo B., Valderrama Márquez I.A., Garzón Aguilar M.I., Martinez de la Barrera L., et al. Outbreak of NDM-1-Producing Klebsiella pneumoniae in a neonatal unit in Colombia. Antimicrob Agents Chemother 2013, 57:1957-1960.
25. Pasteran F., Mora M.M., Albornoz E., Faccone D., Franco R., Ortellado J., et al. Emergence of genetically unrelated NDM-1-producing Acinetobacter pittii strains in Paraguay. J Antimicrob Chemother 2014, 69:2575-2578.
26. Carvalho-Assef A.P., Pereira P.S., Albano R.M., Berião G.C., Chagas T.P., Timm L.N., et al. Isolation of NDM-producing Providencia rettgeri in Brazil. J Antimicrob Chemother 2013, 68:2956-2957.
27. Carvalho-Assef A.P., Pereira P.S., Albano R.M., Berião G.C., Tavares C.P., Chagas T.P., et al. Detection of NDM-1-, CTX-M-15-, and qnrB4-producing Enterobacter hormaechei isolates in Brazil. Antimicrob Agents Chemother 2014, 58:2475-2476.
28. Rozales F.L., Ribeiro V.B., Magagnin C.M., Pagano M., Lutz L., Falci D.R., et al. Emergence of NDM-1-producing Enterobacteriaceae in Porto Alegre, Brazil. Int J Infect Dis 2014, 25:79-81. 10.1016/j.ijid.2014.01.005.
29. PAHO/WHO. Epidemiological update. Carbapenemases of type New Delhi metallo-(-lactamase (NDM), 7 March 2014. PAHO; 2014.
30. Martínez-Martínez L., Pascual A., Jacoby G.A. Quinolone resistance from a transferable plasmid. Lancet 1998, 351:797-799.
31. Castanheira M., Pereira A.S., Nicoletti A.G., Pignatari A.C., Barth A.L., Gales A.C. First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America. Antimicrob Agents Chemother 2007, 51:1527-1529.
32. Minarini L.A., Poirel L., Cattoir V., Darini A.L., Nordmann P. Plasmid-mediated quinolone resistance determinants among enterobacterial isolates from outpatients in Brazil. J Antimicrob Chemother 2008, 62:474-478.
33. Minarini L.A., Gales A.C., Darini A.L. First report of plasmid-mediated resistance to quinolones and cefotaxime in an Enterobacter cloacae strain isolated from an outpatient in Brazil. Antimicrob Agents Chemother 2007, 51:401-402.
34. Viana A.L., Cayo R., Avelino C.C., Gales A.C., Franco M.C., Minarini L.A. Extended-spectrum beta-lactamases in Enterobacteriaceae isolated in Brazil carry distinct types of plasmid-mediated quinolone resistance genes. J Med Microbiol 2013, 62:1326-1331.
35. Fonseca E.L., Dos Santos Freitas F., Vieira V.V., Vicente A.C. New qnr gene cassettes associated with superintegron repeats in Vibrio cholerae O1. Emerg Infect Dis 2008, 14:1129-1131.
36. Cruz G.R., Radice M., Sennati S., Pallecchi L., Rossolini G.M., Gutkind G., et al. Prevalence of plasmid-mediated quinolone resistance determinants among oxyiminocephalosporin-resistant Enterobacteriaceae in Argentina. Mem Inst Oswaldo Cruz 2013, 108:924-927.
37. Quiroga M.P., Andres P., Petroni A., Soler Bistue A.J., Guerriero L., Vargas L.J., et al. Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina. Antimicrob Agents Chemother 2007, 51:4466-4470.
38. Andres P., Lucero C., Soler-Bistué A., Guerriero L., Albornoz E., Tran T., et al. Differential distribution of plasmid-mediated quinolone resistance genes in clinical enterobacteria with unusual phenotypes of quinolone susceptibility from Argentina. Antimicrob Agents Chemother 2013, 57:2467-2475.
39. Bartoloni A., Pallecchi L., Riccobono E., Mantella A., Magnelli D., Di Maggio T., et al. Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America. Clin Microbiol Infect 2013, 19:356-361.
40. Pallecchi L., Riccobono E., Mantella A., Bartalesi F., Sennati S., Gamboa H., et al. High prevalence of qnr genes in commensal enterobacteria from healthy children in Peru and Bolivia. Antimicrob Agents Chemother 2009, 53:2632-2635.
41. Riveros M., Riccobono E., Durand D., Mosquito S., Ruiz J., Rossolini G.M., et al. Plasmid-mediated quinolone resistance genes in enteroaggregative Escherichia coli from infants in Lima, Peru. Int J Antimicrob Agents 2012, 39:540-542.
42. Bado I., Cordeiro N.F., Robino L., Garcia-Fulgueiras V., Seija V., Bazet C., et al. Detection of class 1 and 2 integrons, extended-spectrum β-lactamases and qnr alleles in enterobacterial isolates from the digestive tract of intensive care unit inpatients. Int J Antimicrob Agents 2010, 36:453-458.
43. Gonzalez F., Araque M. Association of transferable quinolone resistance determinant qnrB19 with extended-spectrum β-lactamases in Salmonella Give and Salmonella Heidelberg in Venezuela. Int J Microbiol 2013, 628185.
44. Livermore D.M., Warner M., Mushtaq S., Doumith M., Zhang J., Woodford N. What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int J Antimicrob Agents 2011, 37:415-419.
45. Falagas M.E., Lourida P., Poulikakos P., Rafailidis P.I., Tansarli G.S. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence. Antimicrob Agents Chemother 2011, 58:654-663.
46. Lee G., Burgess D. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports. Ann Clin Microbiol Antimicrob 2012, 11:32. 10.1186/1476-0711-11-32.
47. Levy Hara G., Gould I., Endimiani A., Pardo P.R., Daikos G., Hsueh P.R., et al. Detection, treatment, and prevention of carbapenemase-producing Enterobacteriaceae: recommendations from an international working group. J Chemother 2013, 25:129-140.
48. Bergamasco M.D., Barroso Barbosa M., de Oliveira Garcia D., Cipullo R., Moreira J.C., Baia C., et al. Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation. Transpl Infect Dis 2012, 14:198-205.
49. Capone A., Giannella M., Fortini D., Giordano A., Meledandri M., Ballardini M., et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect 2013, 19:E23-E30.
50. Daikos G.L., Petrikkos P., Psichogiou M., Kosmidis C., Vryonis E., Skoutelis A., et al. Prospective observational study of the impact of VIM-1 metallo-β-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009, 53:1868-1873.
51. Tumbarello M., Viale P., Viscoli C., Trecarichi E.M., Tumietto F., Marchese A., et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012, 55:943-950.
52. Zarkotou O., Pournaras S., Tselioti P., Dragoumanos V., Pitiriga V., Ranellou K., et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect 2011, 17:1798-1803.
53. Souli M., Galani I., Antoniadou A., Papadomichelakis E., Poulakou G., Panagea T., et al. An outbreak of infection due to β-lactamase Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in a Greek university hospital: molecular characterization, epidemiology, and outcomes. Clin Infect Dis 2010, 50:364-373.
54. Souli M., Kontopidou F.V., Papadomichelakis E., Galani I., Armaganidis A., Giamarellou H. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-β-lactamase in a Greek university hospital. Clin Infect Dis 2008, 46:847-854.
55. Qureshi Z., Paterson D., Potoski B., Kilayko M., Sandovsky G., Sordillo E., et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother 2012, 56:2108-2113.
56. Samonis G., Maraki S., Karageorgopoulos D.E., Vouloumanou E.K., Falagas M.E. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis 2012, 31:695-701.
57. Michalopoulos A., Virtzili S., Rafailidis P., Chalevelakis G., Damala M., Falagas M.E. Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clin Microbiol Infect 2010, 16:184-186.
58. Karageorgopoulos D.E., Miriagou V., Tzouvelekis L.S., Spyridopoulou K., Daikos G.L. Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases. J Antimicrob Chemother 2012, 67:2777-2779.
59. Pontikis K., Karaiskos I., Bastani S., Dimopoulos G., Kalogirou M., Katsiari M., et al. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria. Int J Antimicrob Agents 2013, 43:52-59.
60. Nabon A., García Gabarrot G., Lopez Vega M., Camou T. Carbapenemasas: situación actual en Uruguay. Abstract AbstrMCE-1. X Encuentro Nacional de Microbiologos 2013.
61. Marquez C., Ingold A., Echeverría N., Acevedo A., Vignoli R., García-Fulgueiras V., et al. Emergence of KPC-producing Klebsiella pneumoniae in Uruguay: infection control and molecular characterization. New Microbes New Infect 2014, 2:58-63.